Mumps primary prevention: Difference between revisions
| Line 19: | Line 19: | ||
|author=Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM | |author=Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM | ||
|url=http://www.journals.uchicago.edu/CID/journal/issues/v45n4/50311/50311.html}}</ref> | |url=http://www.journals.uchicago.edu/CID/journal/issues/v45n4/50311/50311.html}}</ref> | ||
==References== | ==References== | ||
Revision as of 17:46, 15 March 2016
|
Mumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mumps primary prevention On the Web |
|
American Roentgen Ray Society Images of Mumps primary prevention |
|
Risk calculators and risk factors for Mumps primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Primary Prevention
The most common preventative measure against mumps is immunization with a mumps vaccine. The vaccine may be given separately or as part of the MMR immunization vaccine which also protects against measles and rubella. In the US, MMR is now being supplanted by MMRV, which adds protection against Chickenpox. The WHO recommends the use of mumps vaccines in all countries with well-functioning childhood vaccination programmes. In the United Kingdom it is routinely given to children at age 15 months. The American Academy of Pediatrics recommends the routine administration of MMR vaccine at ages 12-15 months and at 4-6 years. In some locations, the vaccine is given again between 4 to 6 years of age, or between 11 and 12 years of age if not previously given. Efficacy of the vaccine depends on the strain of the vaccine, but is usually around 80%.[1],[2] The Jeryl Lynn strain is most commonly used in developed countries, but has been shown to have reduced efficacy in epidemic situations. The Leningrad-Zagreb strain is commonly used in developing countries, but appears to have superior efficacy in epidemic situations.[3]
References
- ↑ Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL (1999). "Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study". BMJ. 319 (7206): 352. PMID 10435956.
- ↑ "Summary". WHO: Mumps vaccine. Retrieved 2006-04-18.
- ↑ Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM (2007). "Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines". Clin Infect Dis. 45: 459&ndash, 66.